CAR T-cell therapy has significantly improved outcomes for B-ALL patients, but relapse still occurs in over 50% of cases, leaving many with limited treatment options. Ongoing research aims to ...

For example, Millipore supplies the QCM Quantitative Cell Migration assay that uses an 8-μM pore ... the fibroblasts migrate but they don't invade, because if they are able to invade, sooner ...